• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Aryl Hydrocarbon Receptor Plays Important Role in Red Cell Development

July 11, 2013

The aryl hydrocarbon receptor (AhR) may play an important physiologicaland functional role in red cell development, according to a new study published in the journal Blood. Using a novel in-vitro serum- and feeder cell-free culture system, researchers showed that functional AhR is expressed in hematopoietic progenitor cells and that activation of AhR resulted in the exponential expansion of these progenitor cells as well as the development of megakaryocyte-and erythroid-lineage cells. Furthermore, modulation of AhR was shown to direct cell fate; chronic AhR agonism favored erythroid differentiation, while acute agonism favored megakaryocyte specification. The study results may potentially allow researchers to generate large quantities of human hematopoietic cells to better understand red cell and platelet development.

Reference

1. Smith, B. W., Rozelle, S. S., Leung, A., Ubellacker, J., Parks, A., Nah, S. K., French D, Gadue P., Monti S., Chui D.H., Steinberg M.H., Frelinger A.L., Michelson A.D., Theberge R., McComb M.E., Costello C.E., Kotton D.N., Mostoslavsky G., Sherr D.H., Murphy, G. J. The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood. 2013; doi: 10.1182/blood-2012-11-466722.

Filed Under

  • News
  • RBC Transfusion

Recommended

  • Behavior Modifications Support Changes to Restrictive RBC Transfusion Practices

  • Minimal Residual Risk for HIV, Hepatitis B, and Hepatitis C from Blood Products

  • Most U.S. Patients are Likely to Find a Match for Hematopoietic Stem-Cell Transplants

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Global Platelet Transfusion Practices for Patients in the ICU

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

  • Caffeine in Donor Blood Reduces Quality of Stored RBCs

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley